Celladon

Celladon Corporation, a biotechnology company, develops and manufactures molecular therapies for the treatment of heart failure. Its products include SERCA2a, an enzyme that regulates calcium cycling and contractility in heart muscle cells; and...

Founded in 2000
Homepage: http://www.celladon.net
Total money raised: $104.8M

92037 2223 Avenida de la Playa
Suite 300
La Jolla
USA CA

Phone: 858-366-4288

Updated on May 22, 2012
Celladon at CrunchBase

Krisztina M. Zsebo CEO
Roger Hajjar Co-Founder and Scientific Advisor
Past

May, 2012

Celladon raised $10M in unattributed round from MPM Capital

Celladon Raises Additional $10M

February, 2012

Celladon raised $43M in unattributed round from Pfizer Venture Investments, Lundbeckfond Ventures, Novartis Venture Funds, GBS Ventures, Johnson & Johnson Development Corporation, and Venrock

Celladon Closes $43M in Funding

November, 2009

Celladon raised $21.8M in a Series C round from Enterprise Partners, Venrock, and Johnson & Johnson Development

Celladon, Inc.: Series C $21.8M

December, 2005

Celladon raised $30M in a Series B round from Kleiner Perkins Caufield & Byers, Domain Associates, Enterprise Partners, and Venrock

Celladon Secures $30 Million in Series B Financing.

thefreelibrary.com

2000

Celladon was founded in 2000